Skip to content

A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents

A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents - Chemoprevention of oral leukoplakia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002933
Enrollment
46
Registered
2009-12-23
Start date
2001-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral leukoplakia

Interventions

One year supplement of 5mg 2 times/day of beta-carotene and 250mg 2 times/day of vitamin C One year supplement of 25mg 2 times/day of vitamin C

Sponsors

Department of Maxillofacial Surgery, Aichi-Gakuin University School of Dentistry
Lead Sponsor
Department of Oral Medicine, WHO Collaborating Centre for Oral Cancer Precancer,King&#39
Collaborator
s College Dental Institute at Guy&#39
Collaborator
s,King&#39
Collaborator
s&amp
Collaborator
St.Thomas&#39
Collaborator
Hospitals London,UK
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Predominantly white lesion of oral mucosa clinically diagnosed as leukoplakia based on the WHO criteria and confirmed histologically 2) Both non-dysplastic and those with mild to moderate dysplasia histo-pathologically 3) Non-smokers or ex-smokers more than 3 months 4) Discontinuing to take any over the counter micronutrient supplements 4 weeks prior to entering the trial

Exclusion criteria

Exclusion criteria: 1) Any other specific disorders that could appear as a white lesion such as frictional keratosis, hairly leukoplakia, leukoedema, oral lichen planus and erythroplakia 2) Severe dysplasia, carcinoma in situ or micro-invasive carcinoma 3) Current smokers 4) Having adverse medical problems 5) Pregnancy

Design outcomes

Primary

MeasureTime frame
Clinical remission

Secondary

MeasureTime frame
Likelihood of malignant transformation

Countries

Japan

Contacts

Public ContactHideo Fukano

Chemoprevention Study Group for Oral Leukoplakia Department of Maxillofacial Surgery, Aichi-Gakuin University School of Dentistry

hifu0125@dpc.aichi-gakuin.ac.jp052-759-2160

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026